Rare Diseases and Orphan Drugs

Rare Disease in Oncology

Submit Abstract Register Now

Rare Oncology disease has a mandate to accost the recent challenges presented by rare cancers and diseases as well cancers that may be predominant in medically unreasonable populations. CCR investigators, both at the laboratory bench and in the clinic, are actively involved in this research studies.  In many cases, the knowledge CCR’s investigators gain from studying and treating rare cancer diseases and related disorders provides them with insights into the mechanisms that underlie other more common malignant syndromes.  It is very worthy consideration for oncologists to keep updated of the latest advancements in oncology, as changes in management of cancer are shown quite common. All eligible patients in whom cancer progresses and for whom no general of care treatment strategies are available should be enrolled in a clinical trial.